Skip to main content
Original communication

Endovascular therapy of subclavian artery occlusive disease involving the vertebral artery origin

Published Online:https://doi.org/10.1024/0301-1526/a000842

Summary. Background: While the majority of subclavian artery (SA) lesions are localized in the proximal segment, the evidence in patients with medial SA disease involving the vertebral artery (VA) origin are scarce. Patients and methods: We retrospectively analyzed all patients who underwent percutaneous revascularization of the SA at our institution. Results: A total of 196 patients were retrospectively analyzed. The majority of SA lesions (n = 163, 83 %) were located in the proximal segment, whereas 28 lesions (14 %) were located in the medial segment, and only 5 lesions (3 %) involved the distal segment. Procedural success was high for both stenosis (96 %) and occlusion (89 %) and did not differ depending on lesion location. Revascularization techniques in the medial segment included stenting of the SA only (13 patients), additional VA balloon-dilatation (6 patients), and bifurcation stenting of the SA and VA using T-stenting technique (9 patients). Outcome after a median of 12 months showed no significant differences in freedom from restenosis between proximal and medial lesions (90 % vs. 95 %; p = 0.67). Conclusions: Endovascular revascularization of SA disease with medial segments involving the VA origin required more complex techniques and showed long-term patency rates comparable to those in lesions located within the proximal SA.

References

  • 1 English JA, Carell ES, Guidera SA, Tripp HF. Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization. Catheter Cardiovasc Interv. 2001;54:8–11. First citation in articleCrossref MedlineGoogle Scholar

  • 2 Shadman R, Criqui MH, Bundens WP, Fronek A, Denenberg JO, Gamst AC, et al. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol. 2004;44:618–23. First citation in articleCrossref MedlineGoogle Scholar

  • 3 Bryan AJ, Hicks E, Lewis MH. Unilateral digital ischaemia secondary to embolisation from subclavian atheroma. Ann R Coll Surg Engl. 1989;71:140–2. First citation in articleMedlineGoogle Scholar

  • 4 Fields WS, Lemak NA. Joint Study of extracranial arterial occlusion. VII. Subclavian steal–a review of 168 cases. JAMA. 1972;222:1139–43. First citation in articleCrossref MedlineGoogle Scholar

  • 5 Olsen CO, Dunton RF, Maggs PR, Lahey SJ. Review of coronary-subclavian steal following internal mammary artery-coronary artery bypass surgery. Ann Thorac Surg. 1988;46:675–8. First citation in articleCrossref MedlineGoogle Scholar

  • 6 Sueoka BL. Percutaneous transluminal stent placement to treat subclavian steal syndrome. J Vasc Interv Radiol. 1996;7:351–6. First citation in articleCrossref MedlineGoogle Scholar

  • 7 AbuRahma AF, Bates MC, Stone PA, Dyer B, Armistead L, Scott Dean L, et al. Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. J Endovasc Ther. 2007;14:698–704. First citation in articleCrossref MedlineGoogle Scholar

  • 8 Edwards WH, Mulherin JL Jr. The surgical reconstruction of the proximal subclavian and vertebral artery. J Vasc Surg. 1985;2:634–42. First citation in articleCrossref MedlineGoogle Scholar

  • 9 Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816. First citation in articleCrossref MedlineGoogle Scholar

  • 10 De Vries JP, Jager LC, Van den Berg JC, Overtoom TT, Ackerstaff RG, Van de Pavoordt ED, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg. 2005;41:19–23. First citation in articleCrossref MedlineGoogle Scholar

  • 11 Przewlocki T, Wrotniak L, Kablak-Ziembicka A, Pieniazek P, Roslawiecka A, Rzeznik D, et al. Determinants of long-term outcome in patients after percutaneous stent-assisted management of symptomatic subclavian or innominate artery stenosis or occlusion. EuroIntervention. 2017;13:1355–64. First citation in articleCrossref MedlineGoogle Scholar

  • 12 Sixt S, Rastan A, Schwarzwalder U, Burgelin K, Noory E, Schwarz T, et al. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv. 2009;73:395–403. First citation in articleCrossref MedlineGoogle Scholar

  • 13 Schillinger M, Haumer M, Schillinger S, Mlekusch W, Ahmadi R, Minar E Outcome of conservative versus interventional treatment of subclavian artery stenosis. J Endovasc Ther. 2002;9:139–46. First citation in articleCrossref MedlineGoogle Scholar

  • 14 Higashimori A, Morioka N, Shiotani S, Fujihara M, Fukuda K, Yokoi Y. Long-term results of primary stenting for subclavian artery disease. Catheter Cardiovasc Interv. 2013;82:696–700. First citation in articleCrossref MedlineGoogle Scholar

  • 15 Chatterjee S, Nerella N, Chakravarty S, Shani J. Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis – a systematic review and meta-analysis. Am J Ther. 2013;20:520–3. First citation in articleCrossref MedlineGoogle Scholar

  • 16 Duda SH, Wiskirchen J, Tepe G, Bitzer M, Kaulich TW, Stoeckel D, et al. Physical properties of endovascular stents: an experimental comparison. J Vasc Interv Radiol. 2000;11:645–54. First citation in articleCrossref MedlineGoogle Scholar

  • 17 Maciejewski DR, Tekieli L, Machnik R, Kablak-Ziembicka A, Przewlocki T, Paluszek P, et al. Simultaneous vertebral and subclavian artery stenting. Postepy Kardiol Interwencyjnej. 2017;13:142–9. First citation in articleMedlineGoogle Scholar

  • 18 Eberhardt O, Naegele T, Raygrotzki S, Weller M, Ernemann U Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg. 2006;43:1145–54. First citation in articleCrossref MedlineGoogle Scholar

  • 19 Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42:2212–6. First citation in articleCrossref MedlineGoogle Scholar

  • 20 Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2011;57:1002–44. First citation in articleCrossref MedlineGoogle Scholar

  • 21 Routledge HC, Morice MC, Lefevre T, Garot P, De Marco F, Vaquerizo B, et al. 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents. JACC Cardiovasc Interv. 2008;1:358–65. First citation in articleCrossref MedlineGoogle Scholar

  • 22 Musialek P, Langwieser N. Commentary: vertebral artery ostial stenosis stenting technique: the concept reversed? J Endovasc Ther. 2015;22:445–8. First citation in articleCrossref MedlineGoogle Scholar

  • 23 Al-Lamee R, Ielasi A, Latib A, Godino C, Mussardo M, Arioli F, et al. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. Am J Cardiol. 2011;108:1055–60. First citation in articleCrossref MedlineGoogle Scholar

  • 24 Langwieser N, Buyer D, Schuster T, Haller B, Laugwitz KL, Ibrahim T. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. J Endovasc Ther. 2014;21:683–92. First citation in articleCrossref MedlineGoogle Scholar

  • 25 Akins PT, Kerber CW, Pakbaz RS. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series. J Invasive Cardiol. 2008;20:14–20. First citation in articleMedlineGoogle Scholar

  • 26 Vajda Z, Miloslavski E, Guthe T, Fischer S, Albes G, Heuschmid A, et al. Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results. AJNR Am J Neuroradiol. 2009;30:1653–6. First citation in articleCrossref MedlineGoogle Scholar

  • 27 Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, et al. Editor’s Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:3–81. First citation in articleCrossref MedlineGoogle Scholar